THE CLINICOMORPHOLOGICAL AND MOLECULAR BIOLOGICAL CHARACTERISTICS OF ADENOMYOSIS CONCURRENT WITH ENDOMETRIAL ADENOCARCINOMA
- Authors: KOGAN E.A1, SIDOROVA I.S2, NIZYAEVA N.V2, DEMURA T.A1, EZHOVA L.S1, UNANYAN A.L2
-
Affiliations:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
- I.M. Sechenov First Moscow State Medical University
- Issue: No 7-2 (2011)
- Pages: 46-50
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246620
- ID: 246620
Cite item
Open Access
Access granted
Abstract
Objective. To study the clinicomorphological and molecular biological characteristics of adenomyosis concurrent with endometrial adenocarcinoma. Material and methods. The study material was uteri removed from 70 patients, including 37 with adenomyosis (AM) concurrent with endometrioid adenocarcinoma (EAC) of the corpus uteri (Group 1) and 33 with AM without EAC (Group 2). Monoclonal and polyclonal antibodies against ApoCas, Ki-67, COX-2, EGFR, VEGF, MMP-2, MMP-9, and TIMP-1 were used as primary antibodies. Results. The clinical features of AM concurrent with EAC were found, which were characterized by a predominance of the symptoms of endometrial carcinoma and the presence of active AM with atypical epithelial hyperplasia. Examination of AM foci revealed the following 4 types of epithelial changes: proliferation-phase type; hyperplasias with and without atypia, and those with atrophy. Immunohistochemical study showed a considerable increase in Ki-67 expression with a less marked rise in ApoCas, as well as COX-2. The activity of VEGF and EGFR enhanced with epithelial changes in the foci of proliferation-phase AM to hyperplasia with atypia. The concomitance of AM and EAC is not incidental, noted for the clinical symptoms and morphological and molecular biological characteristics of AM. This fact is confirmed by not on1y the high rate of EAC concurrent with AM, the probable common source of origin - basal endometrial cells, and the presence of epithelial hyperplasia with atypia in the foci of AM in patients with cancer of the corpus uteri. Adenomyosis differs from EAC not only morphologically, but also in the expression of molecular markers in the epithelial cells: it shows the high activity of E-cadherin, preserved close contacts with membrane claudin 3 and 5 staining; significant TIMP-1 expression with the high activity of metalloproteinases (MMP). This all determines differences in the mechanisms of invasion: unlike adenocarcinoma, AM spreads by invasion of stromal cells.
Keywords
Full Text
About the authors
E. A KOGAN
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
I. S SIDOROVA
I.M. Sechenov First Moscow State Medical UniversityDepartment of Obstetrics and Gynecology, Therapy Faculty One
N. V NIZYAEVA
I.M. Sechenov First Moscow State Medical University
Email: niziaeva@gmail.com
Department of Morbid Anatomy, Therapy Faculty
T. A DEMURA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
L. S EZHOVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
A. L UNANYAN
I.M. Sechenov First Moscow State Medical UniversityDepartment of Obstetrics and Gynecology, Therapy Faculty One
References
- Адамян Л.В., Кулаков В.И. Эндометриозы. - М., 2006.
- Бохман Я.В. Лекции по онкогинекологии. - M.: МИА, 2007.
- Герасимов А.Н. Медицинская статистика: Учебное пособие. - М.: МИА, 2007.
- Дамиров М.М. Аденомиоз. - М., 2004.
- Коган Е.А., Унанян А.Л., Демура Т.А. и др. Клиникоморфологические параллели и молекулярные аспекты морфогенеза аденомиоза // Арх. пат. - 2008. - T. 70, № 5. - C. 8-12.
- Kairi-Vassilatou E., Kontogianni K., Salamalekis M. et al. A clinicopathological study of the relationship between adenomyosis and other hormone-dependent uterine lesions // Eur. J. Gynaecol. Oncol. - 2004. - Vol. 25, № 2. -Р. 222-224.
- Lee S.K., Moon J., Park Sw. Loss of the tight junction protein claudin-4 correlates with histological growth pattern and differentiation in advanced gastric adenocarcinoma // Oncol. Reports. - 2005. - Vol.13. - P. 193-199.
- Pathology and genetics of tumors of the breast and female genital organs. World Health Organization classification of tumours/Eds F.A.Tavassoli, P. Devilee. - Lyon, 2003.
- Pan X.Y., Wang B., Che Y.C. et al. Expression of claudin-3 and claudin-4 in normal, hyperplasic, and malignant endometrial tissue // Int. J. Gynecol. Cancer. - 2007. - Vol. 17, № 1. -Р. 233-241.
- Robboy,s pathology of the female reproductive tract // Eds S.J. Robboy et al. - 2nd ed. Philadelphia, 2009. - Р. 450-453.
- Samuelsson B., Morgenstern R. et al. Membrane prostaglandin E synthase-1: A novel therapeutic target // Pharmacol. Rev. -2007. - Vol. 59. - P. 207-224.
- Shaco-Levy R., Sharabi S. et al. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neuplastic eutopic endometrium // Eur. J. Obstet. Gynecol. Reprod. Biol. - 2008. - Vol. 139, № 2. - Р. 226-232.
- Sivridis E., Giatromanolaki A. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma // Clin. Pathol. - 2004. - Vol. 57. - P. 840-844.
- Stacey A., Missmer S., Hankinson E., Spiegelman D. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors // Am. J. Epidemiol. - 2004. - Vol. 160, № 8. - Р. 784-796.
- Steven G., Silverberg M.D. The endometrium: Pathologic principles and pitfalls // Arch. Pathol. Lab Med. - 2007. -Vol. 131. - P. 372-382.
- Williams gynecology // Eds J.O. Schorge et al. - New York: Mc Graw Hill, 2008.
Supplementary files
